Agilon Health (NYSE:AGL) Releases Quarterly Earnings Results, Beats Estimates By $0.92 EPS

Agilon Health (NYSE:AGL) issued its quarterly earnings data on Wednesday. The company reported $1.04 EPS for the quarter, topping the consensus estimate of $0.12 by $0.92, FiscalAI reports. The company had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.45 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.

Agilon Health Price Performance

AGL traded up $11.77 during midday trading on Wednesday, hitting $106.55. The stock had a trading volume of 1,114,194 shares, compared to its average volume of 354,879. Agilon Health has a 1 year low of $7.48 and a 1 year high of $133.04. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The business has a fifty day moving average of $106.46 and a 200 day moving average of $54.68. The company has a market cap of $1.78 billion, a P/E ratio of -4.94 and a beta of 3.01.

Wall Street Analyst Weigh In

A number of research firms have commented on AGL. Benchmark reissued a “buy” rating and issued a $95.00 price target (up from $13.00) on shares of Agilon Health in a research note on Thursday, May 21st. Jefferies Financial Group upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $27.50 to $48.00 in a research report on Thursday, May 7th. Weiss Ratings downgraded shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 27th. Deutsche Bank Aktiengesellschaft upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and upped their target price for the stock from $33.00 to $49.00 in a research report on Thursday, May 7th. Finally, Robert W. Baird increased their target price on Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Five analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $66.50.

Institutional Investors Weigh In On Agilon Health

Institutional investors have recently made changes to their positions in the business. AQR Capital Management LLC grew its holdings in shares of Agilon Health by 243.3% during the 1st quarter. AQR Capital Management LLC now owns 501,440 shares of the company’s stock valued at $2,171,000 after purchasing an additional 355,365 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Agilon Health by 3.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock valued at $927,000 after buying an additional 7,209 shares during the period. Dynamic Technology Lab Private Ltd boosted its position in Agilon Health by 28.4% during the first quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after buying an additional 10,424 shares during the period. Goldman Sachs Group Inc. grew its stake in shares of Agilon Health by 6.6% during the first quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock valued at $21,911,000 after buying an additional 311,158 shares during the last quarter. Finally, Creative Planning grew its stake in shares of Agilon Health by 17.6% during the second quarter. Creative Planning now owns 170,969 shares of the company’s stock valued at $393,000 after buying an additional 25,548 shares during the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.